# Peraso Inc.: financial statements, quarterly

PRSO · Nasdaq · CIK 890394 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prso.md) · [Financials](/companies/prso/financials.md) · [Filings](/companies/prso/filings.md) · [Insiders](/companies/prso/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prso/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,481](/filings/0001213900-23-086175.md) | [1,833 d](/filings/0001213900-24-027971.md) | [2,816](/filings/0001213900-24-042928.md) | [4,238](/filings/0001213900-24-068354.md) | [3,841](/filings/0001213900-24-097140.md) | [3,678 d](/filings/0001013762-25-004082.md) | [3,869](/filings/0001213900-26-056603.md) | [2,220](/filings/0001213900-26-089119.md) | [3,234](/filings/0001213900-25-108587.md) | [2,870 d](/filings/0001213900-26-036514.md) | [963](/filings/0001213900-26-056603.md) | [1,307](/filings/0001213900-26-089119.md) |
| Cost of revenue | $k | [2,445](/filings/0001213900-24-097140.md) | [4,531 d](/filings/0001013762-25-004082.md) | [1,510](/filings/0001213900-25-042240.md) | [1,887](/filings/0001213900-25-075801.md) | [2,034](/filings/0001213900-25-108587.md) | [1,609 d](/filings/0001213900-26-036514.md) | [1,189](/filings/0001213900-26-056603.md) | [1,147](/filings/0001213900-26-089119.md) | [1,417](/filings/0001213900-25-108587.md) | [1,373 d](/filings/0001213900-26-036514.md) | [371](/filings/0001213900-26-056603.md) | [474](/filings/0001213900-26-089119.md) |
| Gross profit | $k | [2,036](/filings/0001213900-24-097140.md) | [(2,698) d](/filings/0001013762-25-004082.md) | [1,306](/filings/0001213900-25-042240.md) | [2,351](/filings/0001213900-25-075801.md) | [1,807](/filings/0001213900-25-108587.md) | [2,069 d](/filings/0001213900-26-036514.md) | [2,680](/filings/0001213900-26-056603.md) | [1,073](/filings/0001213900-26-089119.md) | [1,817](/filings/0001213900-25-108587.md) | [1,497 d](/filings/0001213900-26-036514.md) | [592](/filings/0001213900-26-056603.md) | [833](/filings/0001213900-26-089119.md) |
| Research and development | $k | [3,484](/filings/0001213900-24-097140.md) | [3,360 d](/filings/0001013762-25-004082.md) | [2,835](/filings/0001213900-25-042240.md) | [2,644](/filings/0001213900-25-075801.md) | [2,158](/filings/0001213900-25-108587.md) | [1,617 d](/filings/0001213900-26-036514.md) | [1,583](/filings/0001213900-26-056603.md) | [1,662](/filings/0001213900-26-089119.md) | [1,528](/filings/0001213900-25-108587.md) | [1,472 d](/filings/0001213900-26-036514.md) | [1,590](/filings/0001213900-26-056603.md) | [1,625](/filings/0001213900-26-089119.md) |
| Selling, general and administrative | $k | [2,112](/filings/0001213900-24-097140.md) | [2,174 d](/filings/0001013762-25-004082.md) | [2,102](/filings/0001213900-25-042240.md) | [2,141](/filings/0001213900-25-075801.md) | [2,349](/filings/0001213900-25-108587.md) | [2,081 d](/filings/0001213900-26-036514.md) | [1,611](/filings/0001213900-26-056603.md) | [1,411](/filings/0001213900-26-089119.md) | [1,479](/filings/0001213900-25-108587.md) | [1,304 d](/filings/0001213900-26-036514.md) | [1,486](/filings/0001213900-26-056603.md) | [1,444](/filings/0001213900-26-089119.md) |
| Operating income | $k | [(3,560)](/filings/0001213900-24-097140.md) | [(8,232) d](/filings/0001013762-25-004082.md) | [(3,631)](/filings/0001213900-25-042240.md) | [(4,475)](/filings/0001213900-25-075801.md) | [(2,700)](/filings/0001213900-25-108587.md) | [(1,629) d](/filings/0001213900-26-036514.md) | [(514)](/filings/0001213900-26-056603.md) | [(1,777)](/filings/0001213900-26-089119.md) | [(1,190)](/filings/0001213900-25-108587.md) | [(1,279) d](/filings/0001213900-26-036514.md) | [(2,484)](/filings/0001213900-26-056603.md) | [(2,236)](/filings/0001213900-26-089119.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(623)](/filings/0001213900-24-097140.md) | [(8,938) d](/filings/0001013762-25-004082.md) | [(2,031)](/filings/0001213900-25-108587.md) | [(4,425)](/filings/0001213900-25-108587.md) | [(2,712)](/filings/0001213900-25-108587.md) | [(1,560) d](/filings/0001213900-26-036514.md) | [(471)](/filings/0001213900-26-089119.md) | [(1,829)](/filings/0001213900-26-089119.md) | [(1,210)](/filings/0001213900-25-108587.md) | [(1,243) d](/filings/0001213900-26-036514.md) | [(2,497)](/filings/0001213900-26-089119.md) | [(2,220)](/filings/0001213900-26-089119.md) |
| Diluted EPS | $ per share | [(0.87)](/filings/0001213900-24-097140.md) | not reported | [(1.07)](/filings/0001213900-25-042240.md) | [(1.88)](/filings/0001213900-25-075801.md) | [(0.98)](/filings/0001213900-25-108587.md) | not reported | [(0.08)](/filings/0001213900-26-056603.md) | [(0.31)](/filings/0001213900-26-089119.md) | [(0.17)](/filings/0001213900-25-108587.md) | not reported | [(0.22)](/filings/0001213900-26-056603.md) | [(0.16)](/filings/0001213900-26-089119.md) |
| Basic EPS | $ per share | [(0.87)](/filings/0001213900-24-097140.md) | not reported | [(1.07)](/filings/0001213900-25-042240.md) | [(1.88)](/filings/0001213900-25-075801.md) | [(0.98)](/filings/0001213900-25-108587.md) | not reported | [(0.08)](/filings/0001213900-26-056603.md) | [(0.31)](/filings/0001213900-26-089119.md) | [(0.17)](/filings/0001213900-25-108587.md) | not reported | [(0.22)](/filings/0001213900-26-056603.md) | [(0.16)](/filings/0001213900-26-089119.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.7](/filings/0001213900-23-086175.md) | [1.6](/filings/0001013762-25-004082.md) | [2.4](/filings/0001213900-24-042928.md) | [1.9](/filings/0001213900-24-068354.md) | [1.3](/filings/0001213900-24-097140.md) | [3.3](/filings/0001213900-26-036514.md) | not reported | not reported | not reported | [2.9](/filings/0001213900-26-036514.md) | not reported | not reported |
| Current assets | $m | [10.2](/filings/0001213900-23-086175.md) | [5.5](/filings/0001013762-25-004082.md) | [7.5](/filings/0001213900-24-042928.md) | [6.7](/filings/0001213900-24-068354.md) | [5.2](/filings/0001213900-24-097140.md) | [6.3](/filings/0001213900-26-036514.md) | [6.0](/filings/0001213900-25-042240.md) | [4.8](/filings/0001213900-25-075801.md) | [5.6](/filings/0001213900-25-108587.md) | [5.5](/filings/0001213900-26-089119.md) | [5.7](/filings/0001213900-26-056603.md) | [5.7](/filings/0001213900-26-089119.md) |
| Total assets | $m | [16.8](/filings/0001213900-23-086175.md) | [10.7](/filings/0001013762-25-004082.md) | [11.5](/filings/0001213900-24-042928.md) | [9.8](/filings/0001213900-24-068354.md) | [7.2](/filings/0001213900-24-097140.md) | [7.2](/filings/0001213900-26-036514.md) | [6.7](/filings/0001213900-25-042240.md) | [5.5](/filings/0001213900-25-075801.md) | [6.2](/filings/0001213900-25-108587.md) | [6.1](/filings/0001213900-26-089119.md) | [6.4](/filings/0001213900-26-056603.md) | [6.8](/filings/0001213900-26-089119.md) |
| Current liabilities | $m | [3.7](/filings/0001213900-23-086175.md) | [4.5](/filings/0001013762-25-004082.md) | [4.4](/filings/0001213900-24-042928.md) | [5.6](/filings/0001213900-24-068354.md) | [4.9](/filings/0001213900-24-097140.md) | [3.5](/filings/0001213900-26-036514.md) | [3.0](/filings/0001213900-25-042240.md) | [2.4](/filings/0001213900-25-075801.md) | [2.5](/filings/0001213900-25-108587.md) | [1.3](/filings/0001213900-26-089119.md) | [1.7](/filings/0001213900-26-056603.md) | [1.8](/filings/0001213900-26-089119.md) |
| Total liabilities | $m | [5.1](/filings/0001213900-23-086175.md) | [6.6](/filings/0001013762-25-004082.md) | [4.8](/filings/0001213900-24-042928.md) | [6.2](/filings/0001213900-24-068354.md) | [5.2](/filings/0001213900-24-097140.md) | [3.7](/filings/0001213900-26-036514.md) | [3.1](/filings/0001213900-25-042240.md) | [2.5](/filings/0001213900-25-075801.md) | [2.6](/filings/0001213900-25-108587.md) | [1.4](/filings/0001213900-26-089119.md) | [1.8](/filings/0001213900-26-056603.md) | [1.9](/filings/0001213900-26-089119.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [11.7](/filings/0001213900-24-097140.md) | [4.1](/filings/0001213900-26-036514.md) | [6.7](/filings/0001213900-25-108587.md) | [3.6](/filings/0001213900-25-108587.md) | [2.0](/filings/0001213900-25-108587.md) | [3.5](/filings/0001213900-26-089119.md) | [3.6](/filings/0001213900-26-089119.md) | [3.0](/filings/0001213900-26-089119.md) | [3.6](/filings/0001213900-25-108587.md) | [4.6](/filings/0001213900-26-089119.md) | [4.6](/filings/0001213900-26-089119.md) | [4.9](/filings/0001213900-26-089119.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,053) d](/filings/0001213900-24-097140.md) | [937 d](/filings/0001013762-25-004082.md) | [(2,550)](/filings/0001213900-25-042240.md) | [(659) d](/filings/0001213900-25-075801.md) | [(683) d](/filings/0001213900-25-108587.md) | [(687) d](/filings/0001213900-26-036514.md) | [(966)](/filings/0001213900-26-056603.md) | [(2,041) d](/filings/0001213900-26-089119.md) | [(1,548) d](/filings/0001213900-25-108587.md) | [(1,055) d](/filings/0001213900-26-036514.md) | [(2,349)](/filings/0001213900-26-056603.md) | [(1,574) d](/filings/0001213900-26-089119.md) |
| Capital expenditure | $k | [2.0 d](/filings/0001213900-24-097140.md) | [1.0 d](/filings/0001013762-25-004082.md) | not reported | not reported | not reported | not reported | not reported | not reported | [34.0 d](/filings/0001213900-25-108587.md) | [28.0 d](/filings/0001213900-26-036514.md) | [183](/filings/0001213900-26-056603.md) | [97.0 d](/filings/0001213900-26-089119.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.0](/filings/0001213900-23-086175.md) | [0.6](/filings/0001213900-24-042928.md) | [0.6](/filings/0001213900-24-068354.md) | [0.7](/filings/0001213900-24-097140.md) | [1.9](/filings/0001213900-25-042240.md) | [2.4](/filings/0001213900-25-075801.md) | [2.8](/filings/0001213900-25-108587.md) | [5.7](/filings/0001213900-26-056603.md) | [0.0](/filings/0001213900-26-089119.md) | [7.3](/filings/0001213900-25-108587.md) | [11.6](/filings/0001213900-26-056603.md) | [0.0](/filings/0001213900-26-089119.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,064,476 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089119.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.